PGR and breast carcinoma: A different scoring method developed to quantify estrogen and progesterone receptors in breast cancers, the Allred score [2, 12], assigns separate categorical scores for the intensity (0–3) and the proportion (0–5) of the biomarkers in immunolabeled specimens, and the final score is the sum of these two scores.